Janssen COVID-19 Vaccine No Longer Authorized for Emergency Use
On Thursday June 1, 2023, the FDA revoked the emergency use authorization (EUA) of the Janssen COVID-19 Vaccine.
On May 22, 2023, Janssen Biotech Inc. requested the voluntary withdrawal of the EUA for this vaccine. Janssen Biotech, Inc. informed the FDA that the last lots of the vaccine purchased by the U.S. Government have expired, there is no demand for new lots of the vaccine in the U.S., and they do not intend to update the strain composition of this vaccine to address emerging variants.
Source: FDA
Posted: June 2023
Janssen COVID-19 Vaccine (SARS-CoV-2 vaccine) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
